India's most comprehensive portal on pharmaceutical News, …
Jan 8, 2025 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Frequency: Weekly (Goes into printing every Tuesday; On stands …
Launched on 21 December 2000, Chronicle Pharmabiz is the No. 1 Pharma news weekly in the South Asian markets; with a target readership that includes 100% coverage of top and middle management pharma professionals across the region.
China NMPA approves Sanofi’s Sarclisa in combo with …
2 days ago · The National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior line of therapy, including ...
News - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Pharma Mart Search - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
About Us - Pharmabiz.com
Mr. Sanjiv D Kaul, is currently the management advisor to ChrysCapital,a leading international consulting firm based in New Delhi.He is the former vice-president and head of corporate affairs, Ranbaxy Laboratories Limited and has been the key driver for Ranbaxy's aggressive internationalisation drive in markets as varied as Africa, Commonwealth of Independent States, Asia - Pacific and China ...
Opportunities in Chinese CBEC market for OTC drugs
May 21, 2024 · Opportunities in Chinese CBEC market for OTC drugs: Suhayl Abidi Tuesday, May 21, 2024, 08:00 Hrs [IST] In 2019, the China National Medical Products Administration sanctioned a trial initiative for the introduction of over-the-counter (OTC) products in Beijing, initially through a bonded warehouse located in the CBEC Free Trade Zone.
PharmaBiz
You could also subscribe to ePharmail, the daily electronic newsletter from Pharmabiz or a special combined package offer for Pharmabiz Services + ePharmail is available at a discounted rate.. For subscription details please click here or drop us an email on subscribe@saffronmedia.in
Chronicle Specials
Nov 28, 2024 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Pharmaceuticals exports report 4.7 per cent growth in August
Sep 23, 2024 · Pharmaceuticals exports report 4.7 per cent growth in August: Gireesh Babu, New Delhi Monday, September 23, 2024, 08:00 Hrs [IST] Exports of drugs and pharmaceuticals from the country registered a growth of 4.67 per cent growth, even as the imports reported a decline of 2.64 per cent during the month of August.